The levels of fasting free fatty acids (FFA) in the plasma of individuals with central obesity are elevated, promoting the fatification of non-adipose tissue, which produces lipotoxic effects on pancreatic beta cells, leading to inhibited insulin secretion and, consequently, inducing insulin resistance [35]. This evidence concerns the gene INS and Abdominal obesity.